Kkr's co-executive chairman Kravis sells $153.76 million in stock

KKR Co-Executive Chairman Henry Kravis sold 1,280,394 shares of KKR on June 2, 2025, for approximately $153.76 million, with prices ranging from $119.80 to $121.67 per share, to be used for personal investments, expenses, and charitable purposes. This sale follows KKR's recent strong Q1 2025 earnings, with an EPS of $1.15 and revenue of $3.11 billion, exceeding expectations, and the announcement of a subordinated notes offering due in 2065. Morgan Stanley upgraded KKR’s stock rating to Overweight and increased the price target to $150, citing favorable macroeconomic conditions.

Analysis

Henry R. Kravis, Co-Executive Chairman of KKR & Co. Inc., sold 1,280,394 shares of common stock on June 2, 2025, totaling approximately $153.76 million, at prices ranging from $119.80 to $121.67 per share, citing personal investments, expenses, and charitable purposes. Despite this sale, Kravis retains over 73 million shares directly and has indicated potential further sales of up to 1.5 million shares within the year. This insider activity is set against a backdrop of strong Q1 2025 performance for KKR, which reported an earnings per share of $1.15 (exceeding the $1.13 estimate) and revenue of $3.11 billion (significantly above the $1.71 billion forecast). KKR is also enhancing its capital structure through a new subordinated notes offering due in 2065. The company's positive trajectory is further supported by Morgan Stanley's upgrade to Overweight with an increased price target of $150 and a 4.5% upward revision to 2026 EPS estimates. InvestingPro data indicates a 'GOOD' financial health score for KKR, with analyst price targets ranging from $127 to $189, and the firm has maintained dividend payments for 16 consecutive years, offering a current yield of 0.61%.

Key Decisions for Investors

• Investors should monitor Henry Kravis's planned additional stock sales, up to 1.5 million shares, while noting his substantial remaining holdings and stated personal financial planning reasons for the recent $153.76 million disposition.
• The robust Q1 2025 financial results, with an EPS of $1.15 and revenue of $3.11 billion significantly beating expectations, coupled with Morgan Stanley's upgrade to Overweight and a $150 price target, reinforce a positive fundamental outlook for KKR.
• Consider KKR's strategic capital activities, including the new subordinated notes offering and its 16-year history of dividend payments (current yield 0.61%), when evaluating the company's financial management and total return potential.
• Evaluate KKR's stock relative to the analyst consensus price target range of $127 to $189, weighing the strong positive sentiment and fundamental improvements against the ongoing insider selling activity.